Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Reynolds, John VDonohoe, Claire L
McGillycuddy, Erin
Ravi, Naraymasamy
O'Toole, Dermot
O'Byrne, Ken
Hollywood, Donal
Affiliation
Department of Surgery, St James's Hospital and Trinity College, Dublin, Ireland. reynoljv@tcd.ieIssue Date
2012-05Keywords
Carcinoma, Squamous Cell/therapyEsophageal Neoplasms/therapy
Esophagogastric Junction/surgery
Adenocarcinoma/therapy
MeSH
AdenocarcinomaAge Factors
Carcinoma, Squamous Cell
Chemoradiotherapy, Adjuvant
Chi-Square Distribution
Disease-Free Survival
Esophageal Neoplasms
Esophagectomy
Esophagogastric Junction
Gastrectomy
Hospital Mortality
Hospitals
Humans
Ireland
Kaplan-Meier Estimate
Lymph Node Excision
Multivariate Analysis
Neoadjuvant Therapy
Neoplasm Invasiveness
Neoplasm Staging
Proportional Hazards Models
Prospective Studies
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Metadata
Show full item recordCitation
Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center. 2012, 143 (5):1130-1137.e1 J. Thorac. Cardiovasc. Surg.Publisher
ElsevierJournal
The Journal of thoracic and cardiovascular surgeryDOI
10.1016/j.jtcvs.2011.12.003PubMed ID
22244551Abstract
Modern series from high-volume esophageal centers report an approximate 40% 5-year survival in patients treated with curative intent and postoperative mortality rates of less than 4%. An objective analysis of factors that underpin current benchmarks within high-volume centers has not been performed.Language
enISSN
1097-685Xae974a485f413a2113503eed53cd6c53
10.1016/j.jtcvs.2011.12.003
Scopus Count
Collections
Related articles
- Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
- Authors: Stiles BM, Mirza F, Coppolino A, Port JL, Lee PC, Paul S, Altorki NK
- Issue date: 2011 Aug
- Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
- Authors: Lee PC, Port JL, Paul S, Stiles BM, Altorki NK
- Issue date: 2009 Jul
- Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.
- Authors: Dittrick GW, Weber JM, Shridhar R, Hoffe S, Melis M, Almhanna K, Barthel J, McLoughlin J, Karl RC, Meredith KL
- Issue date: 2012 May
- Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
- Authors: Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E
- Issue date: 2011 Dec
- Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years.
- Authors: Internullo E, Moons J, Nafteux P, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Lerut T
- Issue date: 2008 Jun